Global Dashboard
Global Health Dashboard
Comprehensive overview of SDG 3 progress tracking health outcomes across 195 countries using WHO World Health Statistics 2025 data.
2025 SDG Progress Alert
According to the UN SDG Report 2025, none of the SDG 3 targets are fully on track to be achieved by 2030. Accelerated action is urgently needed across all health indicators.
| Target | Description | 2030 Goal | Current Status | Progress |
|---|---|---|---|---|
| 3.1 | Reduce maternal mortality ratio | <70 per 100,000 | 223 per 100,000 | Off Track |
| 3.2 | End preventable child deaths | <25 per 1,000 | 37 per 1,000 | Mixed Progress |
| 3.3 | End epidemics of AIDS, TB, malaria | End epidemics | TB leading killer | Off Track |
| 3.4 | Reduce premature NCD mortality by 1/3 | 33% reduction | 18M deaths/year | Off Track |
| 3.5 | Prevent substance abuse | Strengthen treatment | 9% coverage | Declining |
| 3.6 | Halve road traffic deaths | 50% reduction | 1.19M deaths | Off Track |
| 3.7 | Universal reproductive healthcare | Universal access | 66% coverage | Mixed Progress |
| 3.8 | Achieve universal health coverage | 100% coverage | SCI = 71 | Off Track |
| 3.9 | Reduce deaths from pollution | Substantial reduction | 6.7M deaths | Off Track |
| 3.a | Strengthen tobacco control | Implement FCTC | 22% prevalence | On Track |
| 3.b | Support R&D and access to medicines | Affordable access | Major gaps remain | Mixed Progress |
| 3.c | Increase health workforce | Address shortages | 10M shortage | Off Track |
| 3.d | Strengthen health security | Build capacity | 57% IHR capacity | Mixed Progress |
Regional Health Analysis
Comparative health indicators across WHO's six regions, highlighting disparities and progress.
Highest Disease Burden Region
Africa carries 24% of global disease burden with only 3% of health workers and 1% of health expenditure. 94% of global malaria deaths occur in this region.
Conflict-Affected Health Systems
Multiple countries in the region face health crises due to ongoing conflicts, displacing millions and disrupting essential services.
Global Disease Burden
Analysis of mortality, morbidity, and risk factors driving the global health landscape.
| Rank | Cause | Deaths (Millions) | % of Total | Trend |
|---|---|---|---|---|
| 1 | Ischemic heart disease | 8.9 | 16% | ↑ Rising |
| 2 | Stroke | 6.6 | 11% | ↔ Stable |
| 3 | COPD | 3.5 | 6% | ↑ Rising |
| 4 | Lower respiratory infections | 2.6 | 5% | ↓ Declining |
| 5 | Trachea/bronchus/lung cancers | 1.9 | 3% | ↑ Rising |
| 6 | Alzheimer's & dementias | 1.9 | 3% | ↑ Rising rapidly |
| 7 | Tuberculosis | 1.3 | 2% | ↔ Resurging |
| 8 | Diabetes mellitus | 1.6 | 3% | ↑ Rising rapidly |
| 9 | Kidney diseases | 1.4 | 2% | ↑ Rising |
| 10 | Road traffic injuries | 1.2 | 2% | ↔ Stable |
Global Health Funding
Analysis of development assistance for health and major funding mechanisms.
2025 Funding Milestone
Gavi 6.0 replenishment secured over $9 billion in June 2025 at the Brussels summit. World Bank-Global Fund partnership MoU for $2 billion signed December 2025.
| Organization | Type | Annual Budget (USD) | Primary Focus |
|---|---|---|---|
| USAID Global Health | Bilateral | $11.2 billion | Maternal/child health, HIV, malaria |
| World Bank Health | Multilateral | $9.8 billion | Health systems, pandemic preparedness |
| The Global Fund | Partnership | $5.4 billion | HIV, TB, malaria |
| PEPFAR | Bilateral | $6.0 billion | HIV/AIDS |
| Gates Foundation | Private | $4.5 billion | Vaccines, infectious diseases |
| WHO | UN Agency | $3.5 billion | Global health leadership, norms |
| Gavi Alliance | Partnership | $2.5 billion | Immunization |
| UNICEF Health | UN Agency | $2.1 billion | Child health, immunization |
| Wellcome Trust | Private | $1.2 billion | Health research |
| CEPI | Partnership | $1.0 billion | Epidemic vaccine R&D |
Target 3.1: Maternal Health
By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births.
Progress Stalled
The maternal mortality ratio has remained essentially unchanged since 2016. At current pace, it would take until 2100 to reach the 2030 target.
Target 3.2: Child Mortality
By 2030, end preventable deaths of newborns and children under 5 years of age.
Historic Progress
2023 marked a historic low of 4.8 million under-5 deaths globally. 133 countries have already met the SDG target of <25 deaths per 1,000 live births.
| Cause | Deaths | % of Total | Preventable |
|---|---|---|---|
| Neonatal conditions | 2.4 million | 47% | 80% |
| Pneumonia | 725,000 | 14% | 90% |
| Diarrhea | 480,000 | 9% | 95% |
| Malaria | 456,000 | 9% | 85% |
| Malnutrition (contributing) | 2.2 million | 45% | 100% |
Target 3.3: Communicable Diseases
End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases.
TB Returns as Leading Infectious Disease Killer
In 2023, tuberculosis reclaimed its position as the world's deadliest infectious disease, surpassing COVID-19.
Malaria Vaccine Rollout
RTS,S and R21 vaccines now recommended by WHO. Over 2 million children vaccinated, with 30+ African countries planning introduction.
Target 3.4: NCDs & Mental Health
By 2030, reduce by one third premature mortality from non-communicable diseases.
Severely Off Track
NCDs cause 41 million deaths annually (74% of all deaths). Progress on reducing premature NCD mortality is far behind the required pace.
Target 3.5: Substance Abuse
Strengthen the prevention and treatment of substance abuse.
Declining Progress
Treatment coverage for substance use disorders has declined from 11% in 2015 to just 9% currently.
Target 3.6: Road Safety
By 2030, halve the number of global deaths and injuries from road traffic accidents.
Target 3.7: Sexual & Reproductive Health
By 2030, ensure universal access to sexual and reproductive health-care services.
Target 3.8: Universal Health Coverage
Achieve universal health coverage, including financial risk protection and access to quality essential health-care services.
UHC Global Monitoring Report 2025
Released December 2025: Service coverage index stands at 71, with 4.6 billion people lacking access to essential health services and 2.1 billion facing financial hardship.
| Domain | Indicator | Coverage | Status |
|---|---|---|---|
| Reproductive Health | Family planning demand satisfied | 77% | Good |
| Maternal/Newborn | Skilled birth attendance | 86% | Good |
| Child Health | DTP3 immunization | 84% | Mixed |
| Infectious Diseases | TB treatment coverage | 87% | Good |
| NCDs | Hypertension treatment | 54% | Poor |
| NCDs | Diabetes treatment | 52% | Poor |
| Access | Essential medicines availability | 58% | Poor |
Target 3.9: Pollution & Contamination
By 2030, substantially reduce deaths from hazardous chemicals and pollution.
Target 3.a: Tobacco Control
Strengthen the implementation of the WHO Framework Convention on Tobacco Control.
On Track for Progress
Tobacco use prevalence has declined from 27% in 2000 to 22% in 2023. This is one of the few SDG 3 targets showing consistent progress.
Target 3.b: Vaccines & Medicines
Support R&D of vaccines and medicines and provide access to affordable essential medicines.
Target 3.c: Health Workforce
Substantially increase health financing and health workforce in developing countries.
Critical Shortage
The global health workforce shortage is projected to reach 10 million by 2030, with the greatest gaps in Africa and South-East Asia.
Target 3.d: Health Security
Strengthen the capacity of all countries for early warning and management of health risks.
Global Pandemic Agreement
In May 2025, WHO member states adopted the global pandemic agreement, establishing new frameworks for pandemic prevention, preparedness, and response.
Global Health Organizations
Key organizations driving progress toward SDG 3.
Healthcare Companies
Major pharmaceutical, medical device, and healthcare technology companies.
Global Health Partnerships
Multi-stakeholder partnerships accelerating progress on health outcomes.
| Partnership | Focus | Partners | Resources |
|---|---|---|---|
| SDG 3 Global Action Plan | Coordinated SDG 3 delivery | 13 multilateral agencies | Coordination mechanism |
| Gavi, the Vaccine Alliance | Immunization | WHO, UNICEF, World Bank, Gates | $9B (2026-2030) |
| The Global Fund | HIV, TB, Malaria | Governments, civil society, private sector | $14.3B (2023-2025) |
| CEPI | Epidemic vaccines | 25+ countries, foundations, industry | $3.5B (2022-2026) |
| Stop TB Partnership | TB elimination | 2,000+ organizations | $13B/year needed |
| Roll Back Malaria | Malaria elimination | 500+ partners | $7.3B/year needed |
| Every Woman Every Child | Women's & children's health | UN, governments, NGOs | $100B mobilized |
| UHC2030 | Universal health coverage | Governments, civil society | Advocacy platform |
Health Innovations
Breakthrough technologies transforming global health.
Revolutionary platform enabling rapid vaccine development. Pipeline now includes HIV, TB, malaria, and cancer vaccines.
Machine learning algorithms matching specialist performance in radiology, pathology, and dermatology. FDA approved 500+ AI/ML devices.
Rapid diagnostics enabling testing at community level. Expanding to HIV, TB, malaria, diabetes, and cardiac markers.
Autonomous drones delivering blood, vaccines, and medicines to remote areas. Rwanda, Ghana pioneering at scale.
One-time treatments curing genetic diseases. Sickle cell, beta-thalassemia, hemophilia approvals. CRISPR entering clinical practice.
Prescription software treating diseases. FDA-approved apps for diabetes, substance abuse, insomnia, ADHD.
Health Impact Calculator
Estimate the potential health impact of investments across different interventions.
Estimated Impact
Latest Updates
Recent developments in global health policy, funding, and outcomes.
Glossary
Key terms and abbreviations used in global health.